Therefore the remainder of the study focused on the mechanisms of SPARC-induced tumor cell survival ± TMZ treatment, and the effects of SPARC, HSP27 or AKT or pAKT inhibition ± TMZ on SPARC-induced survival, using the above established cell lines and primary human glioma cell lines. The gene discussed is AKT1; the disease is central nervous system cancer.